Optogenetic Gene Therapy Shows Early Vision Gains in Trial
Restore Vision reports encouraging interim Phase 1/2 clinical trial results for RV-001, an optogenetic gene therapy restoring sight in retinitis pigmentosa.
Optogenetic Gene Therapy Shows Early Vision Gains in Trial Read More